ERIC ROSENBAUM: Open Payments
NPI 1447662762 · WEST BLOOMFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 20 payments from 10 companies in 2025. Trend: 2023 $491 · 2024 $436 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $84 |
| ABBVIE INC. | 3 | $60 |
| Amgen Inc. | 3 | $55 |
| PFIZER INC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, OTEZLA, UBRELVY, Wegovy, JARDIANCE, GEMTESA, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across MI — which companies pay providers there.
